Takeda Pharmaceutical Co. Ltd. ADR (TAK) Social Stream
Featured Post From StockTwits About TAK
$CEMI Seems to me that the company would be a perfect takeover target considering the asset base in the diagnostic tests.NevadaKid, published August 12, 2021
Especially with the depressed share price down from a recent high of $7.34 and having the dual test that differentiates between Covid and the flu pending approval.
Potential suitors are $JNJ, $AZN, $DGX, and $TAK.
The company has business relationships with all of them.
The mandates for Covid testing at all levels of government and in the schools and businesses will require more than one billion tests over the next year.
Chembio has the right test.
Shorts need millions of shares. Buy a few shares today before the next p.r.